[Tranexamic acid in the prevention of oropharyngeal radiomucositis].
The therapeutic effect of tranexamic acid in prevention of radiomucositis has been evaluated in a double blind study. The results suggest that tranexamic acid can be the useful for the treatment of radiomucositis in head and neck cancer patients submitted to radiotherapy.
D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D009092:Mucous Membrane / Q000528:radiation effects; D009960:Oropharynx / Q000528:radiation effects*; D010612:Pharyngitis / Q000517:prevention & control*; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000517:prevention & control*; D014148:Tranexamic Acid / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid
L'acido tranexamico nella prevenzione delle radiomucositi a livello oro-faringeo.